My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    Photodynamic therapy in the anti-VEGF era.

    Fine HF.

    Br J Ophthalmol. 2007 Jun;91(6):707-8. No abstract available. PMID: 17510474 [PubMed - indexed for MEDLINE]Related articles

    2.

    Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.

    Aggio FB, Melo GB, Höfling-Lima AL, Eid Farah M.

    Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. No abstract available. PMID: 17083553 [PubMed - indexed for MEDLINE]Related articles

    3.

    Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.

    Busch T.

    Retina. 2009 Jun;29(6 Suppl):S36-8.PMID: 19553798 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Antiangiogenic therapy]

    Arias Barquet L.

    Arch Soc Esp Oftalmol. 2005 Aug;80(8):435-6. Spanish. No abstract available. PMID: 16136393 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The new face of age-related macular degeneration.

    Giuliari GP, Ciardella AP.

    Can J Ophthalmol. 2007 Aug;42(4):629-30. No abstract available. PMID: 17641716 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.

    Querques G.

    Am J Ophthalmol. 2009 Feb;147(2):375-6; author reply 376-7. No abstract available. PMID: 19166716 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antiangiogenic therapy in neovascular age-related macular degeneration.

    Lin RC, Rosenfeld PJ.

    Int Ophthalmol Clin. 2007 Winter;47(1):117-37. Review. No abstract available. PMID: 17237677 [PubMed - indexed for MEDLINE]Related articles

    8.

    Anti-VEGF therapy: riding the wave of change.

    Hunyor AP.

    Clin Experiment Ophthalmol. 2008 Jul;36(5):401-2. No abstract available. PMID: 18925912 [PubMed - indexed for MEDLINE]Related articles

    9.

    Necessity of paracentesis before or after intravitreal injection of bevacizumab.

    Huang WC, Lin JM, Chiang CC, Tsai YY.

    Arch Ophthalmol. 2008 Sep;126(9):1314-5; author reply 1315. No abstract available. PMID: 18779502 [PubMed - indexed for MEDLINE]Related articles

    10.

    Combination therapy for age-related macular degeneration.

    Patel S.

    Retina. 2009 Jun;29(6 Suppl):S45-8.PMID: 19553801 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.

    Calvo-González C, Reche-Frutos J, Donate-López J, García-Feijoó J, Leila M, Fernández-Pérez C, Garcia-Sánchez J.

    Br J Ophthalmol. 2008 Jan;92(1):74-5.PMID: 18156376 [PubMed - indexed for MEDLINE]Related articles

    12.

    A review of drug options in age-related macular degeneration therapy and potential new agents.

    Yeoh J, Sims J, Guymer RH.

    Expert Opin Pharmacother. 2006 Dec;7(17):2355-68. Review.PMID: 17109611 [PubMed - indexed for MEDLINE]Related articles

    13.

    Editorial: update on the modern management of wet age-related macular degeneration.

    Devenyi RG.

    Can J Ophthalmol. 2006 Apr;41(2):133-8. No abstract available. PMID: 16767199 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series]

    Meyer CH, Helb HM, Eter N.

    Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. Review. German. PMID: 18256841 [PubMed - indexed for MEDLINE]Related articles

    15.

    Current and emerging concepts in the management of neovascular age-related macular degeneration.

    Maloney SC, Godeiro KD, Odashiro AN, Burnier MN Jr.

    Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):147-54. Review.PMID: 17430137 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]

    [No authors listed]

    Klin Monbl Augenheilkd. 2007 Jul;224(7):559-66. German. PMID: 17657689 [PubMed - indexed for MEDLINE]Related articles

    17.

    Vascular endothelial growth factor biology: clinical implications for ocular treatments.

    Bhisitkul RB.

    Br J Ophthalmol. 2006 Dec;90(12):1542-7. Review.PMID: 17114590 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?

    la Cour M.

    Acta Ophthalmol Scand. 2007 Feb;85(1):2-4. No abstract available. PMID: 17244202 [PubMed - indexed for MEDLINE]Related articles

    19.

    Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.

    Shah GK, Sang DN, Hughes MS.

    Retina. 2009 Feb;29(2):133-48. Review.PMID: 19202423 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

    Kourlas H, Abrams P.

    Clin Ther. 2007 Sep;29(9):1850-61. Review.PMID: 18035187 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity